Doyle Wealth Management Abbott Laboratories Transaction History

Doyle Wealth Management

$1.16 Billion
Q3 2022

A detailed history of Doyle Wealth Management transactions in Abbott Laboratories stock. As of the latest transaction made, Doyle Wealth Management holds 104,077 shares of ABT stock, worth $11.9 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares

104,077

Previous 103,645 0.42%

Holding current value

$11.9 Million

Previous $11.3 Million 10.57%

% of portfolio

0.87%

Previous 0.91%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	BUY	$96.76 - $112.03 $41,800 - $48,396	432 Added 0.42%	104,077 $10.1 Million
Q2 2022 Aug 10, 2022	BUY	$102.07 - $123.37 $362,246 - $437,840	3,549 Added 3.55%	103,645 $11.3 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $119,949 - $146,270	1,052 Added 1.06%	100,096 $11.8 Million
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $150,766 - $184,605	1,305 Added 1.34%	99,044 $13.9 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $261,318 - $289,094	2,240 Added 2.35%	97,739 $11.5 Million
Q2 2021 Aug 03, 2021	BUY	$105.79 - $124.53 $480,286 - $565,366	4,540 Added 4.99%	95,499 $11.1 Million
Q1 2021 May 07, 2021	BUY	$108.84 - $128.23 $520,908 - $613,708	4,786 Added 5.55%	90,959 $10.9 Million
Q4 2020 Feb 04, 2021	BUY	$105.0 - $114.42 $376,635 - $410,424	3,587 Added 4.34%	86,173 $9.44 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $3.46 Million - $4.2 Million	-37,731 Reduced 31.36%	82,586 $8.99 Million
Q2 2020 Aug 06, 2020	SELL	$76.57 - $98.0 $21,822 - $27,930	-285 Reduced 0.24%	120,317 $11 Million
Q1 2020 Apr 29, 2020	BUY	$62.82 - $91.86 $210,258 - $307,455	3,347 Added 2.85%	120,602 $9.52 Million
Q4 2019 Feb 11, 2020	SELL	$78.51 - $87.4 $28,106 - $31,289	-358 Reduced 0.3%	117,255 $10.2 Million
Q3 2019 Nov 05, 2019	SELL	$81.84 - $88.74 $14,485 - $15,706	-177 Reduced 0.15%	117,613 $9.84 Million
Q2 2019 Aug 15, 2019	SELL	$72.88 - $85.0 $149,768 - $174,675	-2,055 Reduced 1.71%	117,790 $9.91 Million
Q1 2019 May 13, 2019	SELL	$66.22 - $80.06 $18,541 - $22,416	-280 Reduced 0.23%	119,845 $9.16 Million
Q4 2018 Feb 08, 2019	SELL	$65.56 - $74.27 $46,678 - $52,880	-712 Reduced 0.59%	120,125 $8.69 Million
Q3 2018 Nov 08, 2018	SELL	$60.81 - $73.36 $80,330 - $96,908	-1,321 Reduced 1.08%	120,837 $8.87 Million
Q2 2018 Aug 08, 2018	SELL	$57.57 - $63.54 $97,926 - $108,081	-1,701 Reduced 1.37%	122,158 $7.45 Million
Q1 2018 May 11, 2018	SELL	$56.27 - $63.62 $111,752 - $126,349	-1,986 Reduced 1.58%	123,859 $7.42 Million
Q4 2017 Feb 07, 2018	SELL	$53.68 - $57.47 $178,486 - $191,087	-3,325 Reduced 2.57%	125,845 $7.18 Million
Q3 2017 Oct 25, 2017	BUY	$48.06 - $53.64 $6.21 Million - $6.93 Million	129,170	129,170 $6.89 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Doyle Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Doyle Wealth Management with notifications on news.

Account

Doyle Wealth Management Abbott Laboratories Transaction History